BCCGRC featured in China Daily
A team of Chinese doctors has adopted a new technique, proven by Western-style clinical studies and biological research, to provide cancer patients with another treatment choice.
The Beijing Clinical Cancer Gene Research Centre, a private research institution focusing on biological genetic therapies for cancer, offers cancer patients a new option – Biological Response Modifier (BRM) therapy.
At a recent press conference held in Beijing, Wang Zeguang, director of the centre, declared the therapy has had more than 10,000 clinical applications in the past four years.
According to the professor of biological chemistry, BRM is based on a vegetal or plant-like extract, which was found to work on malignant tumours during research on AIDS.
Categories Media | Tags:
You can follow any follow up comments to this entry through the RSS 2.0 feed.
Leave a Reply
By submitting a comment here you grant BCCGRC a perpetual license to reproduce your words and name/web site in attribution. Inappropriate or irrelevant comments will be removed at an admin's discretion.